AstraZeneca’s New COPD Drug Cuts Lung Attacks by Around 30% in Late-Stage Trials
LONDON, Sept 9: AstraZeneca's experimental treatment for chronic obstructive pulmonary disease (COPD) has demonstrated significant…
Independent , Honest and Dignified Journalism